Hirokazu Matsushita Department of Immunotherapeutics (Medinet) University of Tokyo Hospital Biography Publications Institution JoVE Articles Hirokazu Matsushita has not added a biography. If you are Hirokazu Matsushita and would like to personalize this page please email our Author Liaison for assistance. Publications 癌症 Exome 分析揭示出癌症 Immunoediting 依赖 T-细胞的机制。 Nature. Feb, 2012 | Pubmed ID: 22318521 Ⅰ 型干扰素有选择性地所需的树突状细胞对肿瘤的免疫排斥反应。 The Journal of Experimental Medicine. Sep, 2011 | Pubmed ID: 21930769 探索肾肿瘤的免疫治疗。 International Journal of Urology : Official Journal of the Japanese Urological Association. Jun, 2011 | Pubmed ID: 21599759 过继免疫治疗晚期非小细胞肺癌使用 Zoledronate 扩展 γδTcells: 我临床研究阶段。 Journal of Immunotherapy (Hagerstown, Md. : 1997). Mar, 2011 | Pubmed ID: 21304399 Batf3 虚透露关键作用的树突状细胞集落细胞毒性 T 细胞免疫功能。 Science (New York, N.Y.). Nov, 2008 | Pubmed ID: 19008445 HERV-K 鉴定压制在使用患者自体血清和其免疫原性肿瘤前列腺癌抗原。 Cancer Immunity : a Journal of the Academy of Cancer Immunology. 2008 | Pubmed ID: 19006261 连接粘附分子 A、 果酱 A,是一个新型的细胞表面标记为长期重新填充造血干细胞。 Blood. Feb, 2008 | Pubmed ID: 17986666 确定特定脑胶质瘤的 RFX4-E 和-F 异构体和患者的体液免疫反应。 Cancer Science. Nov, 2005 | Pubmed ID: 16271074 A 激酶锚定蛋白 3 信使 RNA 表达,在卵巢癌和及其对预后的意义。 International Journal of Cancer. Journal International Du Cancer. Jan, 2004 | Pubmed ID: 14618620 扩展人外周血γδT细胞使用Zoledronate Makoto Kondo1,2, Takamichi Izumi1,2, Nao Fujieda1,2, Atsushi Kondo1,2, Takeharu Morishita1,2, Hirokazu Matsushita1, Kazuhiro Kakimi1 1Department of Immunotherapeutics (Medinet), University of Tokyo Hospital, 2MEDINET Co., Ltd JoVE 3182 Immunology and Infection
扩展人外周血γδT细胞使用Zoledronate Makoto Kondo1,2, Takamichi Izumi1,2, Nao Fujieda1,2, Atsushi Kondo1,2, Takeharu Morishita1,2, Hirokazu Matsushita1, Kazuhiro Kakimi1 1Department of Immunotherapeutics (Medinet), University of Tokyo Hospital, 2MEDINET Co., Ltd JoVE 3182 Immunology and Infection